F Morabito Selected Research

Multiple Myeloma

9/2016	A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy.
1/2016	A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma.
11/2012	miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1.
6/2008	Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma.
1/2007	Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Morabito Research Topics

Disease

8	Neoplasms (Cancer) 01/2017 - 08/2001
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 01/2005
5	Multiple Myeloma 09/2016 - 01/2007
3	Breast Neoplasms (Breast Cancer) 10/2013 - 11/2001
3	Obesity 04/2006 - 06/2000
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2017 - 08/2012
2	Leukemia 01/2017 - 03/2000
2	Mucositis 09/2016 - 11/2001
2	Hodgkin Disease (Hodgkin's Disease) 02/2006 - 12/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2002 - 04/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2001 - 03/2000
2	Prader-Willi Syndrome (Syndrome, Prader-Willi) 05/2001 - 04/2000
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2019
1	Vomiting 09/2016
1	Diarrhea 09/2016
1	Plasma Cell Leukemia 01/2014
1	Visceral Leishmaniasis (Kala Azar) 10/2010
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2010
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 06/2009
1	Cognitive Dysfunction 01/2008
1	Body Weight (Weight, Body) 08/2005
1	Lymphoma (Lymphomas) 12/2004
1	Erectile Dysfunction 04/2004
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 07/2003
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2002
1	Aspergillosis 07/2002
1	Fever (Fevers) 11/2001
1	Infections 11/2001
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 12/2000
1	Fatty Liver 06/2000
1	Weight Loss (Weight Reduction) 04/2000
1	Acute Promyelocytic Leukemia 03/2000

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 01/2017 - 08/2012
3	Bortezomib (Velcade)FDA Link 01/2016 - 06/2008
2	Bendamustine Hydrochloride FDA Link 09/2016 - 03/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2014 - 06/2008
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2013 - 01/2010
2	Estrogen ReceptorsIBA 10/2013 - 01/2010
2	fludarabineIBA 10/2012 - 07/2002
2	Rituximab (Mabthera)FDA Link 03/2010 - 07/2003
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2008 - 01/2007
1	Immunoglobulin A (IgA)IBA 01/2019
1	Melphalan (Alkeran)FDA LinkGeneric 09/2016
1	Long Noncoding RNAIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	ofatumumab FDA Link 03/2014
1	Lenalidomide (CC 5013)FDA Link 01/2014
1	Sp1 Transcription FactorIBA 11/2012
1	mouse MIRN29 microRNAIBA 11/2012
1	RetinoidsIBA 10/2012
1	ABT-737IBA 10/2012
1	FenretinideIBA 10/2012
1	liposomal amphotericin B FDA Link 10/2010
1	AntigensIBA 03/2010
1	Biomarkers (Surrogate Marker)IBA 01/2010
1	defibrotideIBA 06/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2008
1	HomocysteineIBA 01/2008
1	Reduced Folate Carrier ProteinIBA 01/2007
1	Uric Acid (Urate)IBA 04/2006
1	Plasminogen Activator Inhibitor 1IBA 04/2006
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2005
1	ChemokinesIBA 01/2005
1	Chemokine CX3CL1IBA 01/2005
1	Proteins (Proteins, Gene)FDA Link 12/2004
1	Sildenafil Citrate (Viagra)FDA Link 04/2004
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2002
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2001
1	Alkylating AgentsIBA 11/2001
1	TM 1IBA 08/2001
1	growth hormone releasing hexapeptideIBA 05/2001
1	Transaminases (Aminotransferases)IBA 06/2000
1	LipidsIBA 06/2000
1	Glucose (Dextrose)FDA LinkGeneric 06/2000
1	Appetite Depressants (Anorectics)IBA 04/2000
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2000
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 03/2000
1	Hemoglobins (Hemoglobin)IBA 03/2000
1	Indicators and Reagents (Reagents)IBA 03/2000
1	Fibrinogen (Factor I)FDA Link 03/2000
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2000

Therapy/Procedure

5	Therapeutics 01/2017 - 11/2001
4	Drug Therapy (Chemotherapy) 01/2010 - 03/2000
3	Stem Cell Transplantation 09/2016 - 02/2006
2	Neoadjuvant Therapy 10/2013 - 01/2010
2	Autologous Transplantation 01/2007 - 04/2002
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 07/2002 - 11/2001
1	Kidney Transplantation 04/2004
1	Salvage Therapy 08/2001
1	Stents 12/2000
1	Biliopancreatic Diversion 04/2000
1	Diet Therapy (Therapy, Diet) 04/2000